Abstract:Zhishen Ruan, 1, &ast Dan Li, 1, &ast Yuanlong Hu, 1 Zhanjun Qiu, 1, 2 Xianhai Chen 1, 2 1 The First Clinical College, Shandong Chinese Medical University, Ji Nan, People's Republic of China; 2 Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji Nan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhanjun Qiu; Xianhai Chen, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji Nan, People's Republic of China, Tel/Fax +86 0531 18660199889, Email ; Background: Acute respiratory failure (ARF) is a common cause of admission to the intensive care unit (ICU) for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). There is still a lack of effective interventions and treatments. ACE inhibitors (ACEI)/ angiotensin II receptor blockers (ARB) were effective in COPD patients. We aimed to study the effect of ACEI/ARB use on AECOPD combined with ARF and evaluate the effect of in-hospital continuation of medication. Methods: We included patients with AECOPD and ARF from the Medical Information Bank for Intensive Care (MIMIC-III) database. MIMIC III is a large cohort database from Boston, USA. Patients were divided into two groups according to the use of ACEI/ARB before admission. Propensity score matching (PSM) was used to reduce potential bias between the two groups. Cox regression and Kaplan-Meier curves compared 30-day mortality in ACEI/ARB users and non-users. We also defined and analyzed the use of in-hospital ACEI/ARB. Multiple models were used to ensure the robustness of the findings. Subgroup analysis was used to analyze the variability between groups. Results: A total of 544 patients were included in the original study. After PSM, 256 patients were included in the matched cohort. Multivariate Cox regression showed 30-day mortality was significantly lower in ACEI/ARB users compared with controls (HR = 0.50, 95% CI: 0.29– 0.86, p = 0.013). In PSM and inverse probability-weighted models, the results are stable Continued in-hospital use of ACEI/ARB remains effective (HR 0.40, 95% CI 0.22– 0.74, p = 0.003). Kaplan-Meier showed a significant difference in survival between the two groups. Conclusion: This study found that pre-hospital ACEI/ARB use was associated with reduced mortality in patients with AECOPD and ARF. Keywords: chronic obstructive pulmonary disease, acute respiratory failure, angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, mortality In the intensive care unit (ICU), acute respiratory failure (ARF) is one of the most frequent complications in patients with acute exacerbations chronic obstructive pulmonary disease (AECOPD). 1,2 Effective treatment options remain limited, and it is necessary to explore appropriate methods to anti-inflammatory and protect against acute lung injury. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor antagonists (ARB), an inhibitor of the renin-angiotensin-aldosterone system, have been widely used in cardiovascular diseases. Previous studies have shown a protective effect of ACEI/AEB in the prognosis of patients with COPD. Mancini reported that the use of ACEI/ARB reduced morbidity and mortality in COPD patients, suggesting its potential dual cardioprotective properties. 3 Subsequently, Mortensen found that patients with AECOPD using ACEI/ARB were associated with lower mortality. 4 There is a lack of studies on ACEI/ARB use in COPD combined with ARF patients admitted to the ICU, and it is unclear whether these patients should continue with ACEI/ARB. We hypothesized that ACEI/ARB would benefit patients with AECOPD and ARF. Hence, we decided to conduct a retrospective study to ascertain the association between ACEI/ARB use and mortality in these patients. This study used a retrospective cohort study. Data were extracted from the Medical Information Bank for Intensive Care (MIMIC)-III (v 1.4). MIMIC-III covered 53423 adult patients hospitalized at the Beth Israel Deaconess Medical Center in Boston from June 2001 to October 2012. 5 One author Zhishen Ruan gained access to the database by completing the online course and passing the National Institutes of "Protecting Human Research Participants Exam" (certification number 43453324). The Institutional Review Board of Beth Israel Deaconess Medical Center and MIT affiliates approved the database. 6 Our findings were reported following the Strengthening the Reporting of Observational Studies in Epidemiology guidelines. 7 We extracted patients with AECOPD and ARF diagnoses f -Abstract Truncated-

The Relationship Between Blood Urea Nitrogen to Creatinine Ratio and Severe Acute Exacerbation of COPD Patients: A Propensity Score Matching Study

The association of blood urea nitrogen levels upon emergency admission with mortality in acute exacerbation of chronic obstructive pulmonary disease

Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU

Elevated BUN Upon Admission as a Predictor of in-Hospital Mortality Among Patients with Acute Exacerbation of COPD: A Secondary Analysis of Multicenter Cohort Study

Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Blood urea nitrogen to creatinine ratio is associated with in-hospital mortality in critically ill patients with venous thromboembolism: a retrospective cohort study

Predictors of Mortality in COPD Exacerbation Cases Presenting to the Respiratory Intensive Care Unit

Comorbidities and Short-Term Prognosis in Patients Admitted to the Intensive Care Unit for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Relationship between blood urea nitrogen to serum albumin ratio and short-term mortality among patients from the surgical intensive care unit: a population-based real-world study

Independent factors associate with hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease requiring intensive care unit admission: Focusing on the eosinophil-to-neutrophil ratio

Blood urea nitrogen to serum albumin ratio: a good predictor of in-hospital and 90-day all-cause mortality in patients with acute exacerbations of chronic obstructive pulmonary disease

A Prediction Model for In-Hospital Mortality of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Patients Based on Red Cell Distribution Width-to-Platelet Ratio

Predictive score for in-hospital mortality in patients with severe AECOPD

Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure

Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Prediction Model of In-Hospital Death for Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients Admitted to Intensive Care Unit: The PD-ICU Score

Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD

Blood Eosinophils and Clinical Outcomes in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Propensity Score Matching Analysis of Real-World Data in China

Blood Urea Nitrogen to Creatinine Ratio and Long-Term Mortality in Patients with Acute Heart Failure: A Prospective Cohort Study and Meta-Analysis

The Association of Renin-Angiotensin System Blockades and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure: A Retrospective Cohort Study

Correlation between serum bilirubin, blood uric acid, and C-reactive protein and the severity of chronic obstructive pulmonary disease